KOD Kodiak Sciences Inc

Price (delayed)

$3.13

Market cap

$164.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.43

Enterprise value

-$9.35M

Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new ...

Highlights
Kodiak Sciences's quick ratio has soared by 64% YoY and by 45% from the previous quarter
The EPS has grown by 25% YoY and by 11% from the previous quarter
The equity has declined by 39% year-on-year and by 9% since the previous quarter

Key stats

What are the main financial stats of KOD
Market
Shares outstanding
52.53M
Market cap
$164.43M
Enterprise value
-$9.35M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.68
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$232.74M
EBITDA
-$205.8M
Free cash flow
-$175.76M
Per share
EPS
-$4.43
Free cash flow per share
-$3.35
Book value per share
$4.59
Revenue per share
$0
TBVPS
$8.28
Balance sheet
Total assets
$434.76M
Total liabilities
$193.57M
Debt
$78.32M
Equity
$241.19M
Working capital
$226.66M
Liquidity
Debt to equity
0.32
Current ratio
10.12
Quick ratio
10.14
Net debt/EBITDA
0.84
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-45.4%
Return on equity
-81.1%
Return on invested capital
-104.9%
Return on capital employed
-56.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KOD stock price

How has the Kodiak Sciences stock price performed over time
Intraday
4.68%
1 week
-3.4%
1 month
18.56%
1 year
-57.06%
YTD
2.96%
QTD
33.19%

Financial performance

How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$248.76M
Net income
-$232.75M
Gross margin
N/A
Net margin
N/A
Kodiak Sciences's net income has increased by 25% YoY and by 11% QoQ
The operating income has grown by 22% YoY and by 10% from the previous quarter

Growth

What is Kodiak Sciences's growth rate over time

Valuation

What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
0.68
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 25% YoY and by 11% from the previous quarter
The stock's P/B is 85% below its 5-year quarterly average of 4.3 and 19% below its last 4 quarters average of 0.8
The equity has declined by 39% year-on-year and by 9% since the previous quarter

Efficiency

How efficient is Kodiak Sciences business performance
KOD's ROIC has dropped by 72% year-on-year
KOD's return on equity is down by 21% year-on-year
The ROA has contracted by 3.4% YoY

Dividends

What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KOD.

Financial health

How did Kodiak Sciences financials performed over time
The total assets is 125% greater than the total liabilities
Kodiak Sciences's quick ratio has soared by 64% YoY and by 45% from the previous quarter
KOD's current ratio has surged by 62% year-on-year and by 46% since the previous quarter
KOD's debt is 68% lower than its equity
KOD's debt to equity is up by 45% YoY and by 3.2% from the previous quarter
The equity has declined by 39% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.